Immunolocalization of transforming growth factor β1, β2, and β3 and insulin-like growth factor I in premature cranial suture fusion

Plastic and Reconstructive Surgery

Volumn 99, Issue 2, 1997, Pages 300-316

  Roth, Douglas A ^b   Gold, Leslie I ^b   Han, Victor K M ^b   McCarthy, Joseph G ^b   Sung, Anne J ^b   Wisoff, Jeffrey H ^b   Longaker, Michael T ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; BONE GROWTH; BONE REMODELING; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; OSSIFICATION; PRIORITY JOURNAL;

CHILD, PRESCHOOL; CRANIAL SUTURES; CRANIOSYNOSTOSES; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INSULIN-LIKE GROWTH FACTOR I; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031031028     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-199702000-00002     Document Type: Article

References (52)

1. Herring, S.W. Epigenetic and Functional Influences on Skull Growth. In J. Hanken and B. K. Hall (Eds.), The Skull, Vol. 1. Chicago: University of Chicago Press, 1993. Chap. 5.
2. Virchow, R. Über den Cretinismus, namentlich in Franken, and über pathologische Schädelformen. Verh. Phys. Med. Ges. Würzburg 2: 230, 1851.
3. Moss, M. L. The pathogenesis of premature cranial synostosis in man. Acta Anat. 37: 351, 1959.
4. McCarthy, J. G., Epstein, F. J., and Wood-Smith, D. Craniosynostosis. In J. G. McCarthy (Ed.), Plastic Surgery, Vol. 4. Philadelphia: Saunders, 1990. Pp. 3013-3053.
5. Kokich, V. G. The Biology of Sutures. In M. M. Cohen (Ed.), Craniosynostosis: Diagnosis, Evaluation and Management. New York: Raven Press, 1986. Pp. 81-103.
6. Kokich, V. G., Moffett, B. C., and Cohen, M. M., Jr. The cloverleaf skull anomaly: An anatomic and histologic study of two specimens. Teratology 26: 105, 1982.
7. Pritchard, J. J., Scott, J. H., and Girgis, F. G. The structure and development of cranial and facial sutures. J. Anat. 90: 73, 1956.
8. Moss, M. L. Inhibition and stimulation of sutural fusion in the rat calvaria. Anat. Rec. 136: 457, 1960.
9. Moss, M. L. Fusion of the frontal suture in the rat. Am. J. Anat. 102: 141, 1958.
10. Smith, H. G., and McKeown, M. Experimental alteration of the coronal sutural area: A histological and quantitative microscopic assessment. J. Anat. 118: 543, 1974.
11. Massler, M., and Schour, I. The growth pattern of the cranial vault in the albino rat as measured by vital staining with alizarine red "S." Anat. Rec. 110: 83, 1951.
12. Alberius, P., and Johnell, O. Immunohistochemical assessment of cranial suture development in rats. J. Anat. 173: 61, 1990.
13. Hobar, P. C., Schreiber, J. S., McCarthy, J. G., and Thomas, P. A. The role of the dura in cranial bone regeneration in the immature animal. Plast. Reconstr. Surg. 92: 405, 1993.
14. Markens, I. S. Transplantation of the future coronal suture on the dura mater of 3- to 4-month-old rats. Acta Anat. 93: 29, 1975.
15. Albright, A. L., and Byrd, R. P. Suture pathology in craniosynostosis. J. Neurosurg. 54: 384, 1981.
16. Reid, C. A., McCarthy, J. G., and Kolber, A. B. A study of regeneration of parietal bone defects in rabbits. Plast Reconstr. Surg. 67: 591, 1981.
17. Pensler, J. M., Ledesma, D. F., Hijjawi, J., and Radosevich, J. A. Plagiocephaly: Premature unilateral closure of the coronal suture: A potentially localized disorder of cellular metabolism. Ann. Plast. Surg. 32: 160, 1994.
18. Bresnick, S., and Schendel, S. Crouzon's disease correlates with low fibroblastic growth factor receptor activity in stenosed cranial sutures. J. Craniofac. Surg. 6: 245, 1995.
19. Bonewald, L. F., and Mundy, G. R. Role of transforming growth factor-beta in bone remodeling. Clin. Orthop. 250: 261, 1990.
20. Centrella, M., Spinelli, H. M., Persing, J. A., and McCarthy, T. L. The complexity of insulin-like growth factors in bone growth and remodeling (Discussion). Ann. Plast. Surg. 31: 434, 1993.
21. Cohick, W. S., and Clemmons, D. R. The insulin-like growth factors. Annu. Rev. Physiol. 55: 131, 1993.
22. Mohan, S., and Baylink, D. J. Bone growth factors. Clin. Orthop. 263: 30, 1991.
23. Centrella, M., McCarthy, T. L., and Canalis, E. Transforming growth factor-beta and remodeling of bone. J. Bone Joint Surg. 73A: 1418, 1991.
24. Centrella, M., McCarthy, T. L., and Canalis, E. Skeletal tissue and transforming growth factor beta. FASEB J. 2: 3066, 1988.
25. Roberts, A. B., and Sporn, M. B. Physiological actions and clinical applications of transforming growth factor-beta (TGF-β). Growth Factors 8: 1, 1993.
26. Massague, J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6: 597, 1990.
27. Canalis, E., McCarthy, T., and Centrella, M. Isolation and characterization of insulin-like growth factor-I (somatomedin C) from cultures of fetal rat calvariae. Endocrinology 122: 22, 1988.
28. Frolik, C. A., Ellis, L. F., and Williams, D. C. Isolation and characterization of insulin-like growth factor-II from human bone. Biochem. Biophys. Res. Commun. 151: 1011, 1988.
29. Joyce, M. E., Roberts, A. B., Sporn, M. B., and Bolander, M. E. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J. Cell Biol. 110: 2195, 1990.
30. Noda, M., and Camilliere, J. J. In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 124: 2991, 1989.
31. Mackie, E. J., and Trechsel, U. Stimulation of bone formation in vivo by transforming growth factor-beta: Remodeling of woven bone and lack of inhibition by indomethacin. Bone 11: 295, 1990.
32. Rosen, D. M., Nathan, R., Armstrong, R., et al. Bone induction and transforming growth factor-beta. Ann. N.Y. Acad. Sci. 593: 98, 1990.
33. Joyce, M. E., Jinguishi, S., and Bolander, M. E. Transforming growth factor-beta in the regulation of fracture repair. Orthop. Clin. North Am. 21: 199, 1990.
34. Beck, L. S., Amento, E. P., Xu, Y., et al. TGF-β1 induces bone closure of skull defects: Temporal dynamics of bone formation in defects exposed to rhTGF-β1. J. Bone Miner. Res. 8: 753, 1993.
35. Beck, L. S., Deguzman, L., Lee, W. P., et al. TGF-β1 induces bone closure of skull defects. J. Bone Miner. Res. 6: 1257, 1991.
36. Thaller, S. R., Hoyt, J., Tesluk, H., and Holmes, R. The effect of insulin growth factor-1 on calvarial sutures in a Sprague-Dawley rat. J. Craniofac. Surg. 4: 35, 1993.
37. Roth, D. A., Bradley, J. P., Levine, J. P., et al. Studies in cranial suture biology: II. The role of the dura in cranial suture fusion. Plast. Reconstr. Surg. 97: 693, 1996.
38. Roth, D. A., Longaker, M. T., McCarthy, J. G., et al. Studies in cranial suture biology: I. Increased immunoreactivity for TGF-β isoforms (β1, β2, and β3) during rat cranial suture fusion. J. Bone Miner. Res. (in press).
39. Pelton, R. W., Saxena, B., Jones, M., et al. Immunohistochemical localization of TGF-β1, TGF-β2, and TGF-β3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J. Cell Biol. 115: 1091, 1991.
40. Mullink, H., Henzen-Logmans, S. C., Tadema, T. M., et al. Influence of fixation and decalcification on the immunohistochemical staining of cell-specific marker in paraffin-embedded human bone biopsies. J. Histochem. Cytochem. 33: 1103, 1985.
41. Han, V. K. M., Lu, F., Bassett, N., et al. Insulin-like growth factor-II (IGF-II) mRNA is expressed in steroidogenic cells in developing ovine adrenal gland: Evidence of an autocrine/paracrine role for IGF-II. Endocrinology 131: 3100, 1992.
42. Bradley, J. P., Roth, D. A., Han, V. K., et al. Increased IGF-I, IGF-II mRNA and IGF-I protein in fusing rat cranial sutures suggest evidence for a paracrine role of IGFs in suture fusion (submitted).
43. McMullen, H. F., Longaker, M. T., Cabrera, R. C., et al. Spatial and temporal expression of TGF-β isoforms (TGF-β1, TGF-β2, and TGF-β3) during ovine excisional and incisional wound repair. Wound Repair Regen. 3: 141, 1994.
44. 1,2 reduces cutaneous scarring in adult rodents. J. Cell Sci. 107: 1137, 1994.
45. Mooney, M. P., Losken, H. W., Siegel, M. L, et al. Development of a strain of rabbits with congenital simple nonsyndromic coronal suture synostosis: II. Somatic and craniofacial growth patterns. Cleft Palate Craniofac. J. 31: 8, 1994.
46. Reardon, W., Winter, R. M., Rutland, P., et al. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genet. 8: 98, 1994.
47. Jabs, E. W., Li, X., Scott, A. F., et al. Jackson-Weiss and Crouzon's syndromes are allelic with mutations in fibroblastic growth factor receptor-2 gene. Nature Genet. 8: 275, 1994.
48. Muenke, M., Schell, U., Hehr, A., et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genet. 8: 269, 1994.
49. Wilkie, A. O. M., Slaney, S. F., Oldridge, M., et al. Apert syndrome cesults from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nature Genet. 9: 165, 1995.
50. Rutland, P., Pulleyn, L. J., Reardon, W., et al. Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nature Genet. 9: 173, 1995.
51. Jones, J. I., and Clemmons, D. R. Insulin-like growth factors and their binding proteins: Biological actions. Endocr. Rev. 16: 3, 1995.
52. Lazowski, D. A., Fraher, L. J., Hodsman, A., et al. Regional variation of insulin-like growth factor-I gene expression in mature rat bone and cartilage. Bone 15: 563, 1994.